{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:09:40Z","timestamp":1790654980188,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1038\/s41433-021-01657-0","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T11:03:51Z","timestamp":1625137431000},"page":"1448-1455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma"],"prefix":"10.1038","volume":"36","author":[{"given":"Nan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5449-1798","authenticated-orcid":false,"given":"Xiaolin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2749-7793","authenticated-orcid":false,"given":"Yaxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2386-0989","authenticated-orcid":false,"given":"Wenbin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"1657_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/jnci\/88.10.675","volume":"88","author":"TR Cot\u00e9","year":"1996","unstructured":"Cot\u00e9 TR, Manns A, Hardy CR, Yellin FJ, Hartge P. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS\/Cancer Study Group. J Natl Cancer Inst. 1996;88:675\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"1657_CR2","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.hoc.2005.05.011","volume":"19","author":"GA Levy-Clarke","year":"2005","unstructured":"Levy-Clarke GA, Chan CC, Nussenblatt RB. Diagnosis and management of primary intraocular lymphoma. Hematol Oncol Clin North Am. 2005;19:739\u201349. viii.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1657_CR3","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1002\/cncr.20300","volume":"100","author":"ME Newell","year":"2004","unstructured":"Newell ME, Hoy JF, Cooper SG, DeGraaff B, Grulich AE, Bryant M, et al. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients. Cancer. 2004;100:2627\u201336.","journal-title":"Cancer"},{"key":"1657_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1023\/A:1006290032052","volume":"43","author":"M Schabet","year":"1999","unstructured":"Schabet M. Epidemiology of primary CNS lymphoma. J Neurooncol. 1999;43:199\u2013201.","journal-title":"J Neurooncol"},{"key":"1657_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3171\/jns.1988.68.6.0835","volume":"68","author":"FH Hochberg","year":"1988","unstructured":"Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg. 1988;68:835\u201353.","journal-title":"J Neurosurg"},{"key":"1657_CR6","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00417-004-0973-0","volume":"242","author":"SE Coupland","year":"2004","unstructured":"Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol. 2004;242:901\u201313.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1657_CR7","first-page":"95","volume":"6","author":"K Jellinger","year":"1975","unstructured":"Jellinger K, Radaskiewicz TH, Slowik F. Primary malignant lymphomas of the central nervous system in man. Acta Neuropathol Suppl. 1975;6:95\u2013102.","journal-title":"Acta Neuropathol Suppl"},{"key":"1657_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y","volume":"88","author":"ND Doolittle","year":"2000","unstructured":"Doolittle ND, Miner ME, Hall WA, Siegal T, Jerome E, Osztie E, et al. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer. 2000;88:637\u201347.","journal-title":"Cancer"},{"key":"1657_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1023\/A:1006266821574","volume":"43","author":"K Hoang-Xuan","year":"1999","unstructured":"Hoang-Xuan K, Delattre JY. Ongoing protocols for non-AIDS primary central nervous system lymphoma [review]. J Neurooncol. 1999;43:287\u201391.","journal-title":"J Neurooncol"},{"key":"1657_CR10","first-page":"1033","volume":"48","author":"DF Kraemer","year":"2001","unstructured":"Kraemer DF, Fortin D, Doolittle ND, Neuwelt EA. Association of total dose intensity of chemotherapy in primary central nervous system lymphoma (human non-acquired immunodeficiency syndrome) and survival. Neurosurgery. 2001;48:1033\u201340. discussion 1040\u20131.","journal-title":"Neurosurgery"},{"key":"1657_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-510X(00)00385-3","volume":"181","author":"U Schlegel","year":"2000","unstructured":"Schlegel U, Schmidt-Wolf IGH, Deckert M. Primary CNS lymphoma. Clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci. 2000;181:1\u201312.","journal-title":"J Neurol Sci"},{"key":"1657_CR12","first-page":"530","volume":"157","author":"RW Zamber","year":"1992","unstructured":"Zamber RW, Kinyoun JL. Radiation retinopathy [published erratum appears in West J Med 1993;158:201]. West J Med. 1992;157:530\u20133.","journal-title":"West J Med"},{"key":"1657_CR13","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/archopht.1997.01100160322009","volume":"115","author":"BC Fishburne","year":"1997","unstructured":"Fishburne BC, Wilson DJ, Rosenbaum JT, Neuwelt EA. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol. 1997;115:1152\u20136.","journal-title":"Arch Ophthalmol"},{"key":"1657_CR14","first-page":"711","volume":"9","author":"TT Batchelor","year":"2003","unstructured":"Batchelor TT, Kolak G, Ciordia R, Foster CS, Henson JW. High-dose methotrexate for intraocular lymphoma. Clin Cancer Res. 2003;9:711\u20135.","journal-title":"Clin Cancer Res"},{"key":"1657_CR15","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S0161-6420(02)01125-9","volume":"109","author":"JR Smith","year":"2002","unstructured":"Smith JR, Rosenbaum JT, Wilson DJ, Doolittle ND, Siegal T, Neuwelt EA, et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology. 2002;109:1709\u201316.","journal-title":"Ophthalmology"},{"key":"1657_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/sj.eye.6700378","volume":"17","author":"PM Hoffman","year":"2003","unstructured":"Hoffman PM, McKelvie P, Hall AJ, Stawell RJ, Santamaria JD. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes. Eye. 2003;17:513\u201321.","journal-title":"Eye"},{"key":"1657_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/bjo.2007.127928","volume":"92","author":"S Frenkel","year":"2008","unstructured":"Frenkel S, Hendler K, Siegal T, Shalom E, Pe\u2019er J. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. Br J Ophthalmol. 2008;92:383\u20138. https:\/\/doi.org\/10.1136\/bjo.2007.127928.","journal-title":"Br J Ophthalmol"},{"key":"1657_CR18","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1200\/JCO.2000.18.17.3144","volume":"18","author":"LE Abrey","year":"2000","unstructured":"Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma; the next step. J Clin Oncol. 2000;18:3144\u201350.","journal-title":"J Clin Oncol"},{"key":"1657_CR19","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.ophtha.2007.03.040","volume":"114","author":"S Goldberg","year":"2007","unstructured":"Goldberg S, Frenkel S, Blumenthal EZ, Solomon A, Pe\u2019er J. Intraocular lymphoma. Ophthalmology. 2007;114:1236\u20137.","journal-title":"Ophthalmology"},{"key":"1657_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ajh.25350","volume":"94","author":"A Castellino","year":"2019","unstructured":"Castellino A, Pulido JS, Johnston PB, Ristow KM, Bennani NN, Inwards DJ, et al. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: a single center experience 1990-2018. Am J Hematol. 2019;94:291\u20138. https:\/\/doi.org\/10.1002\/ajh.25350.","journal-title":"Am J Hematol"},{"key":"1657_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0039-6257(79)90158-9","volume":"23","author":"J Cunha-Vaz","year":"1979","unstructured":"Cunha-Vaz J. The blood-ocular barriers. Surv Ophthalmol. 1979;23:279\u201396.","journal-title":"Surv Ophthalmol"},{"key":"1657_CR22","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.1999.17.4.1326c","volume":"17","author":"JW Henson","year":"1999","unstructured":"Henson JW, Yang J, Batchelor T. Intraocular methotrexate level after high-dose intravenous infusion [letter]. J Clin Oncol. 1999;17:1329.","journal-title":"J Clin Oncol"},{"key":"1657_CR23","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/s0002-9394(14)70444-1","volume":"121","author":"MD de Smet","year":"1996","unstructured":"de Smet MD, Stark-Vancs V, Kohler DR, Smith J, Wittes R, Nussenblatt RB. Intraocular levels of methotrexate after intravenous administration. Am J Ophthalmol. 1996;121:442\u20134. https:\/\/doi.org\/10.1016\/s0002-9394(14)70444-1.","journal-title":"Am J Ophthalmol"},{"key":"1657_CR24","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1200\/JCO.2005.13.524","volume":"23","author":"LE Abrey","year":"2005","unstructured":"Abrey LE, Batchelor TT, Ferreri AJM, Gospodarowicz M, Pulczynski EJ, Zucca E, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol. 2005;23:5034\u201343. https:\/\/doi.org\/10.1200\/JCO.2005.13.524.","journal-title":"J Clin Oncol"},{"key":"1657_CR25","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archopht.117.6.761","volume":"17","author":"VA White","year":"1999","unstructured":"White VA, Gascoyne RD, Paton KE. Use of the polymerase chain reaction to detect B- and T-cell gene rearrangements in vitreous specimens from patients with intraocular lymphoma. Arch Ophthalmol. 1999;17:761\u20135.","journal-title":"Arch Ophthalmol"},{"key":"1657_CR26","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s00417-003-0749-y","volume":"241","author":"SE Coupland","year":"2003","unstructured":"Coupland SE, Bechrakis NE, Anastassiou G, Foerster AM, Heiligenhaus A, Pleyer U, et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome. Graefes Arch Clin Exp Ophthalmol. 2003;241:860\u201370. https:\/\/doi.org\/10.1007\/s00417-003-0749-y.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1657_CR27","first-page":"410","volume-title":"Ophthalmic Surgery: Principles and Practice","author":"WE Benson","year":"1982","unstructured":"Benson WE. Vitrectomy. In: Spaeth GL, ed. Ophthalmic Surgery: Principles and Practice. Philadelphia: W.B. Saunders; 1982. p. 410\u201330."},{"key":"1657_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<543::AID-CNCR17>3.0.CO;2-4","volume":"77","author":"CH Rhodes","year":"1996","unstructured":"Rhodes CH, Glantz MJ, Glantz L, Lekos A, Sorenson GD, Honsinger C, et al. A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer. 1996;77:543\u20138. 10.1002\/(SICI)1097-0142(19960201)77:3<543::AID-CNCR17>3.0.CO;2-4.","journal-title":"Cancer"},{"key":"1657_CR29","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0161-6420(98)99036-4","volume":"105","author":"DF Shen","year":"1998","unstructured":"Shen DF, Zhuang Z, LeHoang P, B\u00f6ni R, Zheng S, Nussenblatt RB, et al. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology. 1998;105:1664\u20139. https:\/\/doi.org\/10.1016\/S0161-6420(98)99036-4.","journal-title":"Ophthalmology"},{"key":"1657_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/s0002-9394(14)72217-2","volume":"120","author":"CC Chan","year":"1995","unstructured":"Chan CC, Whitcup SM, Solomon D, Nussenblatt RB. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol. 1995;120:671\u20133. https:\/\/doi.org\/10.1016\/s0002-9394(14)72217-2.","journal-title":"Am J Ophthalmol"},{"key":"1657_CR31","first-page":"2462","volume":"40","author":"RR Buggage","year":"1999","unstructured":"Buggage RR, Whitcup SM, Nussenblatt RB, Chan CC. Using interleukin 10 to interleukin 6 ratio to distinguish primary intraocular lymphoma and uveitis [letter]. Invest Ophthalmol Vis Sci. 1999;40:2462\u20133.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1657_CR32","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/0002-9394(86)90536-2","volume":"102","author":"RH Millay","year":"1986","unstructured":"Millay RH, Klein ML, Shults WT, Dahlborg SA, Neuwelt EA. Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier. Am J Ophthalmol. 1986;102:626\u201332. https:\/\/doi.org\/10.1016\/0002-9394(86)90536-2.","journal-title":"Am J Ophthalmol"},{"key":"1657_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/cncr.20339","volume":"101","author":"ET Wong","year":"2004","unstructured":"Wong ET, Tishler R, Barron L, Wu JK. Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas. Cancer. 2004;101:139\u201345. https:\/\/doi.org\/10.1002\/cncr.20339.","journal-title":"Cancer"},{"key":"1657_CR34","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1038\/sj.eye.6702804","volume":"21","author":"AS Kitzmann","year":"2007","unstructured":"Kitzmann AS, Pulido JS, Mohney BG, Baratz KH, Grube T, Marler RJ, et al. Intraocular use of rituximab. Eye. 2007;21:1524\u20137. https:\/\/doi.org\/10.1038\/sj.eye.6702804.","journal-title":"Eye"},{"key":"1657_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2019.1594219","volume":"3","author":"JL Biccler","year":"2019","unstructured":"Biccler JL, Savage KJ, Brown PDN, J\u00f8rgensen J, Larsen TS, Poulsen CB, et al. Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphoma. Leuk Lymphoma. 2019;3:1\u20138. https:\/\/doi.org\/10.1080\/10428194.2019.1594219.","journal-title":"Leuk Lymphoma"},{"key":"1657_CR36","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/bjo.83.4.448","volume":"83","author":"MD de Smet","year":"1999","unstructured":"de Smet MD, Vancs VS, Kohler D, Solomon D, Chan CC. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol. 1999;83:448\u201351. https:\/\/doi.org\/10.1136\/bjo.83.4.448.","journal-title":"Br J Ophthalmol"},{"key":"1657_CR37","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s10384-005-0327-4","volume":"50","author":"JK Wang","year":"2006","unstructured":"Wang JK, Yang CM, Lin CP, Shan YD, Lo AY, Tien HF. An Asian patient with intraocular lymphoma treated by intravitreal methotrexate. Jpn J Ophthalmol. 2006;50:474\u20138. https:\/\/doi.org\/10.1007\/s10384-005-0327-4.","journal-title":"Jpn J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01657-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01657-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01657-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T10:13:31Z","timestamp":1656065611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01657-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1657"],"URL":"https:\/\/doi.org\/10.1038\/s41433-021-01657-0","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"assertion":[{"value":"19 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study followed the tenets of the Declaration of Helsinki and its ethical standards of 1964. The study was approved by the Medical Ethics Committee of the Beijing Tongren Hospital, and written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors consent to publish the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}